Latanoprostene Bunod Patent Expiration

Latanoprostene Bunod is Used for reducing intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It was first introduced by Bausch And Lomb Inc in its drug Vyzulta on Nov 2, 2017.


Latanoprostene Bunod Patents

Given below is the list of patents protecting Latanoprostene Bunod, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Vyzulta US6211233 Prostaglandin pharmaceutical compositions Jun 17, 2018

(Expired)

Bausch And Lomb
Vyzulta US7273946 Prostaglandin derivatives Oct 03, 2025 Bausch And Lomb
Vyzulta US7629345 Prostaglandin derivatives Jan 05, 2025 Bausch And Lomb
Vyzulta US7910767 Prostaglandin derivatives Jan 05, 2025 Bausch And Lomb
Vyzulta US8058467 Prostaglandin derivatives Feb 21, 2029 Bausch And Lomb


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Latanoprostene Bunod's patents.

Given below is the list recent legal activities going on the following patents of Latanoprostene Bunod.

Event Date Patent/Publication
Patent litigations
Patent Term Extension Certificate 18 Mar, 2024 US8058467
Withdrawal of Application for PTE 18 Mar, 2024 US7273946
Withdrawal of Application for PTE 18 Mar, 2024 US7629345
Notice of Final Determination -Election Required 13 Feb, 2024 US7273946
Notice of Final Determination -Election Required 13 Feb, 2024 US7629345
Notice of Final Determination -Election Required 13 Feb, 2024 US8058467
Resp. to req. for info. sent under 37 CFR 1.750 02 Feb, 2024 US7629345
Resp. to req. for info. sent under 37 CFR 1.750 02 Feb, 2024 US7273946
Resp. to req. for info. sent under 37 CFR 1.750 02 Feb, 2024 US8058467
Requirement for information sent under 37 CFR 1.750 26 Jan, 2024 US8058467



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳